Dolutegravir-Based ART is Superior to Standard of Care in Young Children Living With HIV (combined results of the main trial and the ‘under 14kg’ cohort)

Authors: Anna Turkova on behalf of the ODYSSEY trial team

Presented at: CHIVA 2021 (Oral presentation)